BSE Live
Oct 10, 16:01Prev. Close
169.35
Open Price
173.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:59Prev. Close
169.46
Open Price
174.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
181.58 (4915)
Balance Sheet of Marksans Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 | |
Total Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 | |
Reserves and Surplus | 2,421.60 | 2,019.74 | 1,699.85 | 1,161.34 | 845.56 | |
Total Reserves and Surplus | 2,421.60 | 2,019.74 | 1,699.85 | 1,161.34 | 845.56 | |
Total Shareholders Funds | 2,466.91 | 2,065.05 | 1,745.16 | 1,202.27 | 886.49 | |
Minority Interest | 22.47 | 20.85 | 19.91 | 20.70 | 18.86 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 3.66 | 10.62 | 15.39 | 17.62 | 8.06 | |
Other Long Term Liabilities | 269.25 | 190.02 | 65.69 | 41.43 | 14.33 | |
Long Term Provisions | 0.00 | 4.56 | 3.25 | 1.86 | 2.11 | |
Total Non-Current Liabilities | 272.91 | 205.20 | 84.33 | 60.91 | 24.50 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 23.09 | 29.09 | 41.59 | 41.29 | 18.74 | |
Trade Payables | 305.70 | 268.28 | 230.60 | 200.08 | 168.66 | |
Other Current Liabilities | 148.56 | 90.53 | 67.48 | 114.12 | 109.14 | |
Short Term Provisions | 0.00 | 1.96 | 1.33 | 0.72 | 1.85 | |
Total Current Liabilities | 477.34 | 389.85 | 340.99 | 356.22 | 298.40 | |
Total Capital And Liabilities | 3,239.63 | 2,680.95 | 2,190.39 | 1,640.10 | 1,228.25 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 886.41 | 675.71 | 379.64 | 341.59 | 248.42 | |
Intangible Assets | 54.62 | 60.73 | 68.17 | 56.69 | 60.94 | |
Capital Work-In-Progress | 9.00 | 5.38 | 7.25 | 0.70 | 5.60 | |
Fixed Assets | 968.14 | 745.85 | 457.69 | 400.86 | 321.04 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 3.86 | 0.80 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 26.44 | 33.11 | 18.91 | 4.16 | 4.16 | |
Total Non-Current Assets | 1,035.51 | 818.46 | 515.09 | 438.90 | 326.00 | |
CURRENT ASSETS | ||||||
Current Investments | 0.74 | 26.99 | 0.54 | 0.44 | 0.00 | |
Inventories | 845.52 | 617.94 | 484.74 | 424.44 | 404.32 | |
Trade Receivables | 540.04 | 453.18 | 416.85 | 394.78 | 271.38 | |
Cash And Cash Equivalents | 704.21 | 673.58 | 714.96 | 349.27 | 212.29 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 113.61 | 90.80 | 58.21 | 32.28 | 14.26 | |
Total Current Assets | 2,204.12 | 1,862.49 | 1,675.30 | 1,201.20 | 902.25 | |
Total Assets | 3,239.63 | 2,680.95 | 2,190.39 | 1,640.10 | 1,228.25 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 34.15 | 45.87 | 9.31 | 17.02 | 19.78 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Current Investments Unquoted Book Value | 0.74 | 26.99 | 0.00 | 0.00 | 0.00 |
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
29.07.2025
07.07.2025
12.06.2025
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y
20.05.2025
Marksans Pharma Standalone March 2025 Net Sales at Rs 299.36 crore, up 32.93% Y-o-Y
28.02.2025
Marksans Pharma Consolidated December 2024 Net Sales at Rs 681.85 crore, up 16.33% Y-o-Y